Press Releases
The American Society of Clinical Oncology and CollabRx Partner to Develop Online Apps for Planning Cancer Treatment
The American Society of Clinical Oncology (ASCO), the world's leading professional organization representing physicians who care for people with cancer, and CollabRx, an organization...
News
Sun Pharma announces USFDA approval for DOCEFREZTM for Injection
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its New Drug Application (NDA) for DOCEFREZTM (docetaxel) for...
News
Almac Introduces selectAZyme
Almac’s biocatalysis business has expanded from its 2009 launch with the sale of six enzyme screening kits, to the current supply of 100s...
Press Releases
Almac Introduces selectAZyme
Almac’s biocatalysis business has expanded from its 2009 launch with the sale of six enzyme screening kits, to the current supply of 100s of...
Industry Reports
Impax Laboratories Reports First Quarter 2011 Financial Results
Impax Laboratories, Inc.reported first quarter ended March 31, 2011 financial results. Larry Hsu, Ph.D., president and CEO, Impax Laboratories, Inc. said, Our revenue related...
News
Seattle Genetics Announces Approval For FDA Accepts Brentuximab Vedotin BLAs
Seattle Genetics, Inc. announced that the U.S. Food and Drug Administration has accepted for filing two Biologics License Applications (BLAs) for brentuximab vedotin, including...
Clinical Trials
FDA approves linagliptin tablets for the treatment of type 2 diabetes
Boehringer Ingelheim and Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved linagliptin tablets, a prescription medication used...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read